Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 59782-89-7 | MDL No. : | MFCD09037455 |
Formula : | C6H5ClIN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RKRUYZVVYJIPRA-UHFFFAOYSA-N |
M.W : | 253.47 | Pubchem ID : | 22602819 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 46.93 |
TPSA : | 12.89 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.84 cm/s |
Log Po/w (iLOGP) : | 2.13 |
Log Po/w (XLOGP3) : | 2.83 |
Log Po/w (WLOGP) : | 2.65 |
Log Po/w (MLOGP) : | 2.33 |
Log Po/w (SILICOS-IT) : | 3.43 |
Consensus Log Po/w : | 2.67 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.69 |
Solubility : | 0.052 mg/ml ; 0.000205 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.76 |
Solubility : | 0.442 mg/ml ; 0.00174 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.98 |
Solubility : | 0.0264 mg/ml ; 0.000104 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.07 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With Ki; sodium thiosulfate In 1,2-dimethoxyethane; acetonitrile; pentane | 19b. 2-Chloro-5-iodo-3-methylpyridine 5-Amino-2-chloro-3-methylpyridine (2.3 g, 16.3 mmol) in DME (9.0 mL) was added dropwise to a solution of boron trifluoride diethyl etherate (3.0 mL, 24.4 mmol) in DME (30.5 mL) at -17° C. After stirring for 15 min, t-butyl nitrite (442 μL, 3.7 mmol) in DME (30.5 mL) was carefully added to the reaction mixture while maintaining the temperature below -5° C. After complete addition the temperature was allowed to gradually warm to 5° C. over 1 hr. The mixture was recooled to -17° C., pentane was added and then decanted. The solid was triturated with pentane (3*) and Et2 O (3*) and then solvent was removed via positive N2 pressure. The crude diazonium tetrafluoroborate salt was dissolved in acetonitrile (15 mL) and KI (3.0 g, 17.9 mmol) was added at -10° C. The reaction was allowed to gradually warm to ambient temperature and stir overnight. A solution of 10percent sodium thiosulfate was carefully added to the reaction mixture which was then poured over Et2 O and the phases separated. The organic phase was dried (MgSO4), concentrated and the residue chromatographed (silica gel; EtOAc/hexane, 1:50) to afford a white solid (3.42 g, 83percent): 1 H NMR (CD3 OD, 300 MHz) δ2.34 (s, 3H),), 8.09 (d, J=2.2 Hz, 1H), 8.42 (d, J=2.2 Hz, 1H). |
[ 153034-88-9 ]
2-Chloro-4-iodo-3-methylpyridine
Similarity: 0.82
[ 550347-54-1 ]
2-Chloro-5-iodo-4-methylpyridine
Similarity: 0.82
[ 887707-25-7 ]
2-Chloro-5-iodo-3-(trifluoromethyl)pyridine
Similarity: 0.80
[ 153034-88-9 ]
2-Chloro-4-iodo-3-methylpyridine
Similarity: 0.82
[ 550347-54-1 ]
2-Chloro-5-iodo-4-methylpyridine
Similarity: 0.82
[ 887707-25-7 ]
2-Chloro-5-iodo-3-(trifluoromethyl)pyridine
Similarity: 0.80